In Stock

Urinary-Pro Urinary Tract Health Support by Bioclinic Naturals 60 tabs

No reviews yet Write a Review
$23.99

 

 

Urinary-Pro Urinary Tract Health Support by Bioclinic Naturals 60 tabs
Urinary-Pro Urinary Tract Health Support by Bioclinic Naturals 60 tabs
Urinary-Pro Urinary Tract Health Support by Bioclinic Naturals 60 tabs
SKU:
9132U
UPC:
629022091324
MPN:
629022091324
Current Stock:
$23.99

 Includes a unique combination of four plant extracts that promote healthy urinary function*

• Has 250 mg of bearberry (Arctostaphylos uva-ursi) per tablet, standardized to 20% of arbutin, which may help support healthy urination and maintain healthy urinary function*
• Berberine hydrochloride supports healthy nuclear factor erythroid 2-related factor 2 (Nrf2) activity involved in antioxidant processes, and helps clear normal cellular debris*
• Juniper and berberine extracts both support urinary health*
• Echinacea purpurea supports healthy immune function*
• Suitable for vegans

Feature Summary

Urinary-Pro includes four plant extracts to support healthy urinary function.* A unique combination of extracts from bearberry (Arctostaphylos uva-ursi), juniper (Juniperus communis), and echinacea (Echinacea purpurea), in addition to berberine, supports antioxidant processes in the urinary tract, supports normal immune function, and maintains healthy urinary mucosa.*

Bearberry has the highest natural content of the phenol arbutin (hydroquinone β-D-glucoside) and has a long history of use in supporting urinary tract health.*1 In one study, women maintained urinary tract health over a one-year period of consuming bearberry.*2 Berberine, well known for its antibacterial properties, has been found to help maintain the integrity of bladder cells and the tissue they form.*3,4,5,6 Berberine has also been shown to help support antioxidant processes, in part by enhancing Nrf-2 activity, a key signaling pathway for antioxidant support.*7

Urinary-Pro also provides a 4:1 extract of juniper, which is involved in antioxidant processes, helps support healthy urination, and helps maintain urinary mucosal health.*8,9,10 A 6:1 extract of Echinacea purpurea supports healthy urinary function by supporting both innate and specific immune activity.* Additionally, it has been shown to support urinary mucosal health.*11,12

Medicinal Ingredients

Supplement Facts
Serving Size 2 Tablets
Servings Per Container 30
Bearberry 10:1 extract (Arctostaphylos uva-ursi) (leaf) 500 mg
Berberine (as berberine hydrochloride) 100 mg
Echinacea 6:1 extract (Echinacea purpurea) (aerial) 100 mg
Juniper 4:1 extract (Juniperus communis) (fruit) 75 mg

Suggested Usage: 2 tablets 2 times per day or as directed by a health care professional. Take a few hours before or after taking any medication or supplement. Do not take with highly acidic foods (e.g., citrus fruits and juice) or medications, which may acidify urine. For occasional use only. Consult a health care professional for use beyond 1 week.

Allergens:

Contains no artificial colors, preservatives, or sweeteners; no dairy, starch, sugar, wheat, gluten, yeast, soy, egg, fish, shellfish, animal products, tree nuts, or GMOs. Suitable for vegetarians/vegans. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.

Drug Interactions

No known drug interactions exist. Berberine has been shown to lower blood glucose levels and may have an additive effect when combined with other hypoglycemic medications, such as metformin.13 Berberine has also been shown to increase levels of cyclosporin A, and combined use should be avoided.14 Berberine has demonstrated inhibitory activity on cytochrome enzymes CYP2D6, CYP3A4, and CYP2C9, and use of medications metabolized by these enzymes should be monitored.15 Echinacea has been shown to reduce the required steroid dosage in inflammatory conditions, and may improve the efficacy of antifungal treatments for infection with Candida sp.16,17,18 Although direct evidence of drug interactions with echinacea is lacking, it is a weak inhibitor of CYP1A2 and a minor inducer of CYP3A4, and may have a slight effect on drugs metabolized through these pathways.19

References:

  1. Asensio, E., Vitales, D., Pérez, I., et al. (2020). Plants (Basel), 9(9), 1250.
  2. Larsson, B., Jonasson, A., & Fianu, S. (1993). Curr Ther Res Clin Exp, 53(4), 441-3.
  3. Petronio, G.P., Cutuli, M.A., Magnifico, I., et al. (2020). Molecules, 25(21), 5010.
  4. Chen, L., Bu, Q., Xu, H., et al. (2016). Microbiol Res, 186-187, 44-51.
  5. Wang, K., Feng, X., Chai, L., et al. (2017). Drug Metab Rev, 49(2), 139-57.
  6. Rabbani, G.H., Butler, T., Knight, J., et al. (1987). J Infect Dis, 155(5), 979-84.
  7. Ashrafizadeh, M., Fekri, H.S., Ahmadi, Z., et al. (2020). J Cell Biochem, 121(2), 1575-85.
  8. Yarnell, E. (2002). World J Urol, 20(5), 285-93.
  9. Klančnik, A., Zorko, Š., Toplak, N., et al. (2018). Phytother Res, 32(3), 542-50.
  10. Fernandez A., & Edwin C.I. (2016). Pharmacogn J, 8(3), 273-80.
  11. Catanzaro, M., Corsini, E., Rosini, M., et al. (2018). Molecules, 23(11), 2778.
  12. Sharifi-Rad, M., Mnayer, D., Morais-Braga, M.F.B, et al. (2018). Phytother Res, 32(9),1653-63.
  13. Zhang, H., Wei, J., Xue, R., et al. (2010). Metabolism, 59(2), 285-92.
  14. Xin, H.-W., Wu, X.-C., Li, Q., et al. (2006). Methods Find Exp Clin Pharmacol, 28(1), 25-9.
  15. Guo, Y., Chen, Y., Tan, Z.-R., et al. (2012). Eur J Clin Pharmacol, 68(2), 213-7.
  16. Manayi, A., Vazirian, M., & Saeidnia, S. (2015). Pharmacogn Rev, 9(17), 63-72.
  17. Coeugniet, E.G., & Kühnast R. (1986). Therapiewoche, 36, 3352-8.
  18. Neri, P.G., Stagni, E., Filippello, M., et al. (2006). J Ocul Pharmacol Ther, 22(6), 431-6.
  19. Freeman, C., & Spelman, K. (2008). Mol Nutr Food Res, 52(7), 789-98.

Product Reviews

Be the first to know about new products, specials & more!

Powered by Top Rated Local®